Gaudet; Francois

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gaudet; Francois.The latest application filed is for "compositions comprising a t cell redirection therapeutic and a vla-4 adhesion pathway inhibitor".

Company Profile

8.4.13

Gaudet; Francois - Princeton NJ
Gaudet; Francois - Spring House PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions Comprising A T Cell Redirection Therapeutic And A Vla-4 Adhesion Pathway Inhibitor App 20210363252 - Nair-Gupta; Priyanka ; et al.	2021-11-25
Prostate specific membrane antigen (PSMA) bispecific binding agents and uses thereof Grant 10,844,122 - Anderson , et al. November 24, 2	2020-11-24
Gprc5d Chimeric Antigen Receptors And Cells Expressing The Same App 20200231686 - Attar; Ricardo ; et al.	2020-07-23
Methods Of Treating Cancers And Enhancing Efficacy Of T Cell Redirecting Therapeutics App 20200190205 - Adams; Homer ; et al.	2020-06-18
Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof Grant 10,562,968 - Attar , et al. Feb	2020-02-18
Anti-cd3 Antibodies And Uses Thereof App 20200048349 - GAUDET; Francois ; et al.	2020-02-13
Anti-cd33 Antibodies, Anti-cd33/anti-cd3 Bispecific Antibodies And Uses Thereof App 20190382481 - Diem; Michael ; et al.	2019-12-19
Methods of Treating Cancers and Enhancing Efficacy of T Cell Redirecting Therapeutics App 20190352421 - Adams; Homer ; et al.	2019-11-21
Anti-il1rap Antibodies, Bispecific Antigen Binding Molecules That Bind Il1rap And Cd3, And Uses Thereof App 20190270826 - Heidrich; Bradley J. ; et al.	2019-09-05
Anti-BCMA antibodies and uses thereof Grant 10,072,088 - Pillarisetti , et al. September 11, 2	2018-09-11
Anti- Gprc5d Antibodies, Bispecific Antigen Binding Molecules That Bind Gprc5d And Cd3, And Uses Thereof App 20180037651 - Attar; Ricardo ; et al.	2018-02-08
CD123 binding agents and uses thereof Grant 9,850,310 - Gaudet , et al. December 26, 2	2017-12-26
Anti-ror1, Antibodies, Ror1 X Cd3 Bispecific Antibodies, And Methods Of Using The Same App 20170210799 - ANDERSON; Glenn Mark ; et al.	2017-07-27
Anti-il1rap Antibodies, Bispecific Antigen Binding Molecules That Bind Il1rap And Cd3, And Uses Thereof App 20170121420 - Heidrich; Bradley J. ; et al.	2017-05-04
Anti-BCMA Antibodies, Bispecific Antigen Binding Molecules that Bind BCMA and CD3, and Uses Thereof App 20170051068 - Pillarisetti; Kodandaram ; et al.	2017-02-23
Prostate Specific Membrane Antigen (PSMA) Bispecific Binding Agents and Uses Thereof App 20160347840 - Anderson; Glenn ; et al.	2016-12-01
CD123 Binding Agents and Uses Thereof App 20160068605 - Nemeth; Jennifer F. ; et al.	2016-03-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.